Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today introduced its investigational peptide-matrix microneedle technology, a dissolving microneedle platform designed to ...
Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today welcomed remarks by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., who said in an interview on Fox ...
Investment advances collaboration on peptide-based products for athletic performance, recovery and longevity. TORONTO, Oct. 7, 2026 /CNW/ -- Vector Science and Therapeutics Corp.
Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that it has entered into a ...
Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced the appointment of Angus ...
14-Year MLB Veteran and 2016 World Series Champion Joins Valor, Vector's Athlete Platform, to Make Sure the Next Generation Plays Longer and Hurts Less MEQUON, Wis., June 12, 2026 /PRNewswire/ -- ...
Vector Science & Therapeutics hires Angus Jackson to lead partnerships and acquisition reviews as the peptide and drug-delivery medtech builds out its leadership.
STCK.WT.C:CAStack Capital Group Inc. WT EXP 033128 STCK.WT.A:CAStack Capital Group Inc. WT EXP 103027 Vector Science and Therapeutics Corp. develops and sells biomechanical devices and active ...
Former Wisconsin Governor and U.S. Secretary of Health and Human Services Brings Extensive Healthcare Leadership to Pioneer of Transdermal Drug Delivery Technology MEQUON, Wis., April 30, 2026 /CNW/ - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results